Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Genocea Biosciences, Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 4.67||$ 16.18|
|Low||$ 4.35||$ 2.56|
The current last sale of $4.39 is 71.48% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
Unless the context requires otherwise, references in this Annual Report on Form 10-K to "Genocea", "we", "us" and "our" refer to Genocea Biosciences, Inc. Overview We are a biopharmaceutical company that discovers and develops novel vaccines and immunotherapies to address diseases with significant unmet needs. We use our proprietary discovery platform, ATLASTM, to rapidly design vaccines and immunotherapies that act, in part, through T cell (or cellular) immune responses, in contrast to approved vaccines and immunotherapies, which are designed to act primarily through B cell (or antibody) immune responses. We believe that by harnessing T cells we can develop first-in-class vaccines and immunotherapies to address diseases where T cells are central to the control of the disease. We have one product candidate in active Phase 2 clinical development, GEN-003, an immunotherapy for the treatment of genital herpes. ... More ...
Where does GNCA fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$-1.74|
|Quarterly EPS Est:||-0.4|